Filter posts

BIO Expands Cooperation with China-Based Pharma Group

Earlier this week BIO signed of a Memorandum of Understanding for Cooperation with the Pharmaceutical Association …

Shooting for the Moon: Creating the Next Generation of Cancer Killers

The last morning of the 2017 BIO International Convention kicked off with a 9:00am oncology …

Expanded Access: New Opportunities for Patients and Sponsors

Patients with serious or life-threatening conditions may find themselves with no treatment options once approved …

City of South San Francisco Recognizes Contributions to Biotech Industry Growth

BIO’s Pete Pellerito yesterday received the City of South San Francisco’s first ever special recognition …

State Leaders Discuss Bioscience Economic Development

This week BIO released Bioscience Innovation in the States: Legislation and Job Creation through Public-Private …

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

#BIO2017 Fireside Chat: Unlocking the Power of the Genome

To Francis deSouza, genomics is a transformational force. deSouza, President and CEO of Illumina, joined …

Invest in Diversity to Drive Innovation

“We’re just looking for someone with the right ‘fit.’”  How many times have you heard …

U.S. Department of Defense Officials Introduce New Strategies to Stimulate Medical Countermeasures D...

For the past several years, BIO has had the opportunity to partner with the U.S. …